A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy

Resolution Criteria Trial: NCT06007690 Selected endpoint key: bc43905e520dabb2034d270945cf0949b80ed82ba2d0c7d5501abfca19b87b6f Selected endpoint: Time to reach tumor progression Endpoint type: other Protocol outcome group: primary Endpoint description: Tumor Progression Endpoint timeframe: 65 weeks ClinicalTrials.gov population: The prespecified primary analysis population Market population: The prespecified primary analysis population Analysis set: The prespecified primary analysis set Comparison: The prespecified comparison in the ClinicalTrials.gov protocol and statistical analysis plan Success direction: custom Success rule: The selected endpoint meets its prespecified statistical success criterion in the approved population and timepoint. ClinicalTrials.gov source: https://clinicaltrials.gov/study/NCT06007690?tab=researcher#outcome-measures:~:text=Time%20to%20reach%20tumor%20progression YES 1. The exact selected endpoint (Time to reach tumor progression) satisfies the approved success rule in the specified population, analysis set, comparison, and timepoint. 2. The result is supported by a qualifying source in the approved evidence hierarchy. NO 1. The exact selected endpoint (Time to reach tumor progression) misses its approved success rule. 2. No qualifying disclosure of the selected endpoint is available by 2027-11-15 at 23:59:59 UTC. NO DECISION / ADMIN REVIEW 1. Available evidence is contradictory, incomplete, pooled, interim, subgroup-only, or does not match the approved population, analysis set, comparison, and timepoint. Resolution deadline: 2027-11-15T23:59:59Z Deadline evidence: ClinicalTrials.gov identifies 2027-11-15 as the exact primary-completion date and market deadline. Deadline evidence source: https://clinicaltrials.gov/study/NCT06007690 Evidence precedence 1. ClinicalTrials.gov posted results 2. Sponsor regulatory filing or official release 3. Peer-reviewed publication or official conference abstract Only the selected endpoint in the specified population, analysis set, comparison, and timeframe can resolve YES. Overall positive messaging, another endpoint, interim results, pooled analyses, or an unmatched subgroup cannot resolve YES.